Informatics
News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year.
Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease
Premium
After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025.
Pathology Firm Paige Gets Microsoft Investment for Cloud-Based AI Dx
The firm plans to deliver clinical applications and computational biomarkers under the agreement, the terms of which were not immediately disclosed.
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.
Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance
As it exits reproductive health screening this quarter, the newly renamed GeneDx expects 2022 revenues of $170 million to $173 million and 2023 revenues of $205 million to $220 million in pursuit of profitability by 2025.